Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Data Science : JDS|March 1, 2012
A Weighted-Least-Squares Estimation Approach to Comparing Trends in Age-Adjusted Cancer Rates Across Overlapping RegionsKimberly A Walters, Yi Li, Ram C Tiwari, et al.
Child and Adolescent Psychiatric Clinics of North America|May 31, 2021
Psychoeducational and Skill-building Interventions for Emotion DysregulationTaban Salem, Kimberly A Walters, Joseph S Verducci, et al.
Human Heredity|June 28, 2014
The value of regenotyping older linkage data sets with denser marker panelsVeronica J Vieland, Kimberly A Walters, Marco Azaro, et al.
The American Journal of Psychiatry|October 31, 2013
Revisiting schizophrenia linkage data in the NIMH Repository: reanalysis of regularized data across multiple studiesVeronica J Vieland, Kimberly A Walters, Thomas Lehner, et al.
Plos One|January 24, 2014
Meta-analysis of repository data: impact of data regularization on NIMH schizophrenia linkage resultsKimberly A Walters, Yungui Huang, Marco Azaro, et al.
Journal of Neurodevelopmental Disorders|October 8, 2013
A molecular genetic study of autism and related phenotypes in extended pedigreesJoseph Piven, Veronica J Vieland, Morgan Parlier, et al.
Nature Medicine|August 8, 2022
Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trialAndrew Feigin, Elizabeth E Evans, Terrence L Fisher, et al.
American Heart Journal|November 1, 2020
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristicsGlenn M Chertow, Pablo E Pergola, Rajiv Agarwal, et al.
The New England Journal of Medicine|April 29, 2021
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing DialysisKai-Uwe Eckardt, Rajiv Agarwal, Ahmad Aswad, et al.
Lancet (London, England)|August 15, 2017
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trialDaniel S Ory, Elizabeth A Ottinger, Nicole Yanjanin Farhat, et al.
Pageof 2